GLP-1 Agonists and Vision Loss: Examining the Potential Risks

GLP-1 Agonists and Vision Loss: Examining the Potential Risks Glucagon-like peptide-1 (GLP-1) agonists have become increasingly popular for managing type 2 diabetes and, more recently, for weight loss. Medications like semaglutide (Ozempic, Wegovy, Rybelsus) and liraglutide (Victoza, Saxenda) have demonstrated significant efficacy in these areas. However, as with any medication, understanding the potential side effects … Read more

close